The accompanying notes are an integral part of the consolidated financial statements.
The accompanying notes are an integral part of the consolidated financial statements.
AWARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Note 1 – Description of the Company and Basis of Presentation
Description of the Company
We are a global leader in biometrics software offerings and solutions. Our portfolio enables government agencies and commercial entities to enroll, identify, authenticate and enable using biometrics, which comprise physiological characteristics, such as fingerprints, faces, irises and voices.
|
• |
Enroll: Register biometric identities into an organization’s secure database |
|
• |
Identify: Utilize an organization’s secure database to accurately identify individuals using biometric data |
|
• |
Authenticate: Provide frictionless multi-factor, passwordless access to secured accounts and databases with biometric verification |
|
• |
Enable: Manage the lifecycle of secure identities through optimized biometric interchanges |
We have been engaged in this business since 1993. Our comprehensive portfolio of biometric solutions is based on innovative, robust products designed explicitly for ease of integration, including customer-managed and integration ready biometric frameworks, platforms, software development kits (SDKs) and services. Principal government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Principal commercial applications include mobile enrollment, user authentication, identity proofing, and secure transaction enablement.
Our products span multiple biometric modalities including fingerprint, face, iris and voice, and provide interoperable, standards-compliant, field-proven biometric functionality. Our products are used to capture, verify, format, compress and decompress biometric images as well as aggregate, analyze, process, match and transport those images and templates within biometric systems. For large deployments, we may provide project management and software engineering services. We sell our biometrics software products and services globally through a multifaceted distribution strategy using systems integrators, original equipment manufacturers (OEMs), value added resellers (VARs), partners, and directly to end user customers.
Certain amounts in the consolidated financial statements and associated notes may not add due to rounding. All percentages have been calculated using unrounded amounts.
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q and therefore do not include all information and notes necessary for a complete presentation of our financial position, results of operations and cash flows, in conformity with generally accepted accounting principles. We filed audited financial statements which included all information and notes necessary for such presentation for the two years ended December 31, 2021 in conjunction with our 2021 Annual Report on Form 10-K. This Form 10-Q should be read in conjunction with that Form 10-K.
The accompanying unaudited consolidated balance sheets, statements of operations, statements of cash flows, and statements of stockholders’ equity reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at June 30, 2022, and of operations and cash flows for the interim periods ended June 30, 2022 and 2021.
The results of operations for the interim periods ended June 30, 2022 are not necessarily indicative of the results to be expected for the year.
8
Principles of Consolidation
The consolidated financial statements include the accounts of Aware, Inc. and its subsidiaries, Aware Security Corporation and Fortr3ss, Inc. Intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, valuation of acquired assets and assumed liabilities in business combinations, valuation of earn-out liability, valuation of the investment in the note receivable, goodwill and long-lived asset impairment and valuation allowance for deferred income tax assets. Actual results could differ from those estimates.
Recent Accounting Pronouncements
In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires contract assets and contracts liabilities to be accounted for as if they (“the acquirer”) entered into the original contract at the same time and same date as the acquiree. The guidance is to be effective for reporting periods beginning after December 15, 2022, with early adoption permitted. We have elected not to early adopt and we are continuing to assess the impact of the standard on our consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, which changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. This guidance was to be effective for reporting periods beginning after December 15, 2019, with early adoption permitted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) Effective Dates, which deferred the effective dates for us, as a smaller reporting company, until fiscal year 2023. We are continuing to assess the impact of the standard on our consolidated financial statements.
Note 2 – Revenue Recognition
We recognize revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, we apply the following five step model:
1.Identify the contract with the customer;
2.Identify the performance obligations in the contract;
3.Determine the transaction price;
4.Allocate the transaction price to the performance obligations in the contract; and
5.Recognize revenue when (or as) each performance obligation is satisfied.
We categorize revenue as software licenses, software maintenance, or services and other. Revenue from software licenses is recognized at a point in time upon delivery, provided all other revenue recognition criteria are met. We recognize software maintenance revenue over time on a straight-line basis over the contract period. Services revenue is recognized over time as the services are delivered using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted), provided all other revenue recognition criteria are met. Other revenue, includes hardware sales that may be included in a software license, is recognized at a point in time upon delivery provided all other revenue recognition criteria are met.
In addition to selling software licenses, software maintenance and software services on a standalone basis, a significant portion of our contracts include multiple performance obligations, which require an allocation
9
of the transaction price to each distinct performance obligation based on a relative standalone selling price (“SSP”) basis. The SSP is the price at which we would sell a promised good or service separately to a customer. The best estimate of SSP is the observable price of a good or service when we sell that good or service separately. A contractually stated price or a list price for a good or service may be the SSP of that good or service. We use a range of selling prices to estimate SSP when we sell each of the goods and services separately and need to determine whether there is a discount that needs to be allocated based on the relative SSP of the various goods and services within multiple performance obligation arrangements. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, we typically determine the SSP using an adjusted market assessment approach using information that may include market conditions and other observable inputs. We typically have more than one SSP for individual goods and services due to the stratification of those goods and services by customer. In these instances, we may use information such as the nature of the customer and distribution channel in determining the SSP.
When software licenses and significant customization engineering services are sold together, they are accounted for as a combined performance obligation, as the software licenses are generally highly dependent on, and interrelated with, the associated customization services and therefore are not distinct performance obligations. Revenue for the combined performance obligation is recognized over time as the services are delivered using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted).
When subscription-based software is sold, the subscription-based software and software maintenance are generally considered distinct performance obligations. The transaction price is allocated to subscription-based software and the software maintenance based on the relative SSP of each performance obligation. We sell subscription-based software for a fixed fee and/or a usage-based royalty fee, sometimes subject to a minimum guarantee. When the amount is in the form of a fixed fee, including the guaranteed minimum in subscription-based royalties, revenue is allocated to the subscription-based software and recognized at a point in time upon delivery, provided all other revenue recognition criteria are met. Revenue allocated to the software maintenance is recognized over the contract term on a straight-line basis. Any subscription-based software fees earned not subject to the guaranteed minimum or earned in excess of the minimum amount are recognized as revenue when the subsequent usage occurs.
Our contracts can include variable fees, such as the option to purchase additional usage of a previously delivered software license. We may also provide pricing concessions to clients, a business practice that also gives rise to variable fees in contracts. We include variable fees in the determination of total transaction price if it is not probable that a future significant reversal of revenue will occur. We use the expected value or most likely value amount, whichever is more appropriate for specific circumstances, to estimate variable consideration, and the estimates are based on the level of historical price concessions offered to clients.
The amount of consideration is not adjusted for a significant financing component if the time between payment and the transfer of the related good or service is expected to be one year or less under the practical expedient in the guidance. Our revenue arrangements are typically accounted for under such expedient, as payment is typically due within 30 to 60 days. As of June 30, 2022 and 2021, none of our contracts contained a significant financing component.
Also, with our acquisition of FortressID and adaption of our current products to be delivered in a hosted environment with AwareID, we expect to recognize revenue from our SaaS offerings in future periods. SaaS offerings are recognized ratably over the subscription period. For the three and six months ended June 30, 2022 and 2021, we did not generate revenue from SaaS contracts.
Disaggregation of Revenues
We organize ourselves into a single segment that reports to the Chief Executive Officer who is our chief operating decision maker. We conduct our operations in the United States and sell our products and
10
services to domestic and international customers. Revenues generated from the following geographic regions for the three and six months ended June 30, 2022 and 2021 were (in thousands):
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
United States |
|
$ |
2,274 |
|
|
$ |
2,445 |
|
|
$ |
4,310 |
|
|
$ |
4,668 |
|
United Kingdom |
|
|
385 |
|
|
|
774 |
|
|
|
762 |
|
|
|
1,453 |
|
Germany |
|
$ |
635 |
|
|
$ |
56 |
|
|
$ |
653 |
|
|
$ |
124 |
|
Rest of World |
|
|
944 |
|
|
|
989 |
|
|
|
3,205 |
|
|
|
2,437 |
|
|
|
$ |
4,238 |
|
|
$ |
4,264 |
|
|
$ |
8,930 |
|
|
$ |
8,682 |
|
Revenue by timing of transfer of goods or services for the three and six months ended June 30, 2022 and 2021 were (in thousands):
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
|
|
2022 |
|
|
2021 |
|
2022 |
|
|
2021 |
|
Goods or services transferred at a point in time |
|
$ |
2,020 |
|
|
$ |
1,614 |
|
$ |
4,713 |
|
|
$ |
4,021 |
|
Goods or services transferred over time |
|
|
2,218 |
|
|
|
2,650 |
|
|
4,217 |
|
|
|
4,661 |
|
|
|
$ |
4,238 |
|
|
$ |
4,264 |
|
$ |
8,930 |
|
|
$ |
8,682 |
|
Revenue by contract type for the three and six months ended June 30, 2022 and 2021 were (in thousands):
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
|
|
2022 |
|
|
2021 |
|
2022 |
|
|
2021 |
|
License and service contracts |
|
$ |
3,884 |
|
|
$ |
3,927 |
|
$ |
7,215 |
|
|
$ |
7,561 |
|
Subscription-based contracts |
|
|
354 |
|
|
|
337 |
|
|
1,715 |
|
|
|
1,121 |
|
|
|
$ |
4,238 |
|
|
$ |
4,264 |
|
$ |
8,930 |
|
|
$ |
8,682 |
|
Revenue from subscription-based contracts include revenue that may be recognized at a point in time or over time and be part of a fixed fee and or minimum guarantee as well as fees earned and allocated to software maintenance.
Contract Balances
When the timing of our delivery of goods or services is different from the timing of payments made by customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance). Customers that prepay are represented by the deferred revenue below until the performance obligation is satisfied.
Our contract assets consist of unbilled receivables. Our contract liabilities consist of deferred (unearned) revenue, which is generally related to software maintenance contracts. We classify deferred revenue as current or noncurrent based on the timing of when we expect to recognize revenue.
11
The following tables present changes in our contract assets and liabilities during the three and six months ended June 30, 2022 and 2021 (in thousands):
|
|
Balance at
Beginning
of Period |
|
|
Revenue
Recognized In
Advance of
Billings |
|
|
Billings |
|
|
Balance at
End of
Period |
|
Three months ended June 30, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unbilled receivables |
|
$ |
2,482 |
|
|
$ |
1,389 |
|
|
$ |
(1,004 |
) |
|
$ |
2,867 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unbilled receivables |
|
$ |
3,175 |
|
|
$ |
1,515 |
|
|
$ |
(1,260 |
) |
|
$ |
3,430 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at
Beginning
of Period |
|
|
Billings |
|
|
Revenue
Recognized |
|
|
Balance at
End of
Period |
|
Three months ended June 30, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred revenue |
|
$ |
3,543 |
|
|
$ |
1,173 |
|
|
$ |
(1,769 |
) |
|
$ |
2,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred revenue |
|
$ |
3,300 |
|
|
$ |
2,052 |
|
|
$ |
(1,819 |
) |
|
$ |
3,533 |
|
|
|
Balance at
Beginning
of Period |
|
|
Revenue
Recognized In
Advance of
Billings |
|
|
Billings |
|
|
Balance at
End of
Period |
|
Six months ended June 30, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unbilled receivables |
|
$ |
2,229 |
|
|
$ |
2,079 |
|
|
$ |
(1,441 |
) |
|
$ |
2,867 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unbilled receivables |
|
$ |
3,087 |
|
|
$ |
3,001 |
|
|
$ |
(2,658 |
) |
|
$ |
3,430 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at
Beginning
of Period |
|
|
Billings |
|
|
Revenue
Recognized |
|
|
Balance at
End of
Period |
|
Six months ended June 30, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred revenue |
|
$ |
3,933 |
|
|
$ |
2,608 |
|
|
$ |
(3,594 |
) |
|
$ |
2,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred revenue |
|
$ |
3,740 |
|
|
$ |
3,274 |
|
|
$ |
(3,481 |
) |
|
$ |
3,533 |
|
Remaining Performance Obligations
Remaining performance obligations represent the transaction price from contracts for which work has not been performed or goods and services have not been delivered. We expect to recognize revenue on approximately 67% of the remaining performance obligations over the next 12 months, with the remainder
12
recognized thereafter. As of June 30, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations for contracts with a duration greater than one year was $2.4 million.
Note 3 – Fair Value Measurements
The FASB Codification defines fair value, and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels of the fair value hierarchy under the FASB Codification are: Level 1 – valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date; Level 2 – valuations that are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and Level 3 – valuations that require inputs that are both significant to the fair value measurement and unobservable.
Cash and cash equivalents, which primarily include money market mutual funds, were $25.0 million and $30.0 million as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022, our assets that are measured at fair value on a recurring basis included the following (in thousands):
|
|
Fair Value Measurement at June 30, 2022 Using: |
|
|
|
Quoted
Prices in
Active
Markets for
Identical
Assets |
|
|
Significant
Other
Observable
Inputs |
|
|
Significant
Unobservable
Inputs |
|
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
Money market funds (included in
cash and cash equivalents) |
|
$ |
23,487 |
|
|
$ |
— |
|
|
$ |
— |
|
Note receivable |
|
|
— |
|
|
|
— |
|
|
|
2,538 |
|
Total assets |
|
$ |
23,487 |
|
|
$ |
— |
|
|
$ |
2,538 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Contingent acquisition payment |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
919 |
|
Total |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
919 |
|
The fair value of the investment in note receivable was negotiated on an arm’s length basis and the total investment of $2.5 million is representative of the total fair value of the investment. The fair value of our contingent acquisition payment was determined using a Monte Carlo simulation and there was no change in fair value from the initial recording date (acquisition date) to June 30, 2022 or December 31, 2021 due to no change in forecasted revenue and a di minimis impact from the present value factor.
As of December 31, 2021, our assets that are measured at fair value on a recurring basis included the following (in thousands):
13
|
|
Fair Value Measurement at December 31,
2021 Using: |
|
|
|
Quoted
Prices in
Active
Markets for
Identical
Assets |
|
|
Significant
Other
Observable
Inputs |
|
|
Significant
Unobservable
Inputs |
|
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
Money market funds (included in
cash and cash equivalents) |
|
$ |
28,952 |
|
|
$ |
— |
|
|
$ |
— |
|
Total assets |
|
$ |
28,952 |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Contingent acquisition payment |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
919 |
|
Total |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
919 |
|
The fair value of our contingent acquisition payment was determined using a Monte Carlo simulation and there was no change in fair value from the initial recording date (acquisition date) to December 31, 2021 due to the proximity of the acquisition to year-end.
14
Note 4 – Acquisition
Fortress - In December 2021, we acquired 100% of the outstanding shares and acquired all of the assets and liabilities of FortressID for a purchase price of $3.4 million, which consisted of $2.5 million of cash consideration and an earnout with a fair value of $0.9 million. The maximum earnout payment is $4.0 million and requires cash payments of up to $2.0 million for set revenue targets in 2022 and another $2.0 million for set revenue targets in 2023. The acquisition of FortressID, expands our offerings around identity proofing-enhancing its onboarding, verification and authentication offerings to directly address financial compliance requirements and enable organizations to mitigate risk and curtail increasing fraud.
The acquisition was accounted for as a business combination, whereby all the assets acquired, and liabilities assumed were recognized at fair value on the acquisition date, with any excess of the consideration transferred over the fair value of the net assets acquired recognized as goodwill. Unaudited pro forma results of operations assuming the above acquisition had taken place at the beginning of each period are not provided because the historical operating results and pro forma results would not be materially different from reported results for the periods presented.
The fair values recorded were based on a valuation performed by a third-party valuation specialist and the estimates and assumptions used in such valuation are subject to change, within the measurement period (up to one year from the acquisition date). The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition (in thousands):
Customer relationships |
|
$ 1,740 |
Developed technology |
|
430 |
Trade name / trademarks |
|
10 |
Goodwill |
|
1,469 |
Gross assets acquired |
|
3,649 |
Net working capital |
|
(11) |
Fair value of contingent consideration |
|
(919) |
Net assets acquired |
|
$ 2,719 |
After allocating the purchase price to the assets acquired and liabilities assumed based on their fair values at the date of acquisition, we recorded goodwill of approximately $1.5 million, which included $0.3 million related to the release of certain deferred tax assets. Goodwill largely consists of expected synergies to be realized from combining operations. The goodwill is deductible for income tax purposes.
Note 5 – Long-Lived Assets Held for Sale
As of June 30, 2022, the Company classified $2.9 million of net property and equipment as “long-lived assets held for sale” on the consolidated balance sheet. These assets are associated with our corporate office which was sold in July 2022 for $8.9 million and resulted in net proceeds of $8.6 million. We will record the gain on the sale of the corporate office and dispose of these assets during the quarter ended September 30, 2022. See Note 12 to these Unaudited Consolidated Financial Statements.
Note 6 – Intangible Assets
The fair value of intangible assets and their estimated useful lives as of June 30, 2022 are as follows (dollars in thousands):
|
|
Useful Life |
|
Gross
Amount |
|
|
Accumulated
Amortization |
|
|
Net Book
Value |
|
Customer relationships |
|
8 and 10 years |
|
$ |
2,680 |
|
|
$ |
278 |
|
|
$ |
2,402 |
|
Developed technology |
|
5 and years |
|
|
710 |
|
|
|
122 |
|
|
|
588 |
|
Trade name trademarks |
|
3 and 7 years |
|
|
30 |
|
|
|
6 |
|
|
|
24 |
|
|
|
|
|
$ |
3,420 |
|
|
$ |
406 |
|
|
$ |
3,014 |
|
15
During the three months ended June 30, 2021 and 2022, we recorded $44 thousand and $0.1 million of intangible assets amortization expense, respectively. During the six months ended June 30, 2021 and 2022, we recorded $0.1 million and $0.2 million of intangible asset amortization expense, respectively. We expect to record amortization expense for the remainder of 2022 and each subsequent year as follows (in thousands):
2022 |
|
$ |
207 |
|
2023 |
|
|
415 |
|
2024 |
|
|
415 |
|
2025 |
|
|
412 |
|
2026 |
|
|
412 |
|
Thereafter |
|
|
1,153 |
|
|
|
$ |
3,014 |
|
Note 7 – Subscription Agreement
On March 11, 2022, concurrently with our entry into a mutual reseller arrangement with MIRACL Technologies Limited (“MIRACL”), we entered into a subscription agreement with Omlis Limited, a limited company incorporated and registered in England and Wales and the parent of MIRACL (“Omlis”). We purchased $2.5 million of Omlis’ Note Receivable (“Note”) that accrues interest at 5% annually with a maturity date of March 11, 2026.
Prior to maturity, we have the right to convert the Note into the securities issued in a future financing at a 20% discount from the price per share paid by the investors in that financing. If the Note remains outstanding on the maturity date, the Note shall, at the option of the holders of a majority of the outstanding Note, (i) be converted into the most senior shares in Omlis, (ii) be redeemed by payment in cash of the Note and all accrued but unpaid interest or (iii) remain outstanding.
In connection with the sale of the Note, Omlis granted us a right of first refusal for 18 months with respect to any proposed sale by Omlis of equity securities constituting 20% or more of the outstanding voting power of Omlis or all or substantially all of the assets of Omlis or any of its material subsidiaries. Also, in connection with the sale of the Note, Omlis issued the Company a warrant that expires on September 11, 2023, which allows us to purchase up to 8% of the total equity shares in Omlis at a price per share of $33.91.
We recorded the Note and warrants at their fair values in accordance with ASC 825, Financial Instruments, for the Note and ASC 815, Derivatives and Hedging, for the warrants, which were $2.5 million and $0, respectively as of June 30, 2022. Interest income of $31 thousand and $38 thousand was earned during the three month and six month periods ended June 30, 2022, respectively. The $38 thousand in accrued interest is included in the fair value of the note as of June 30, 2022. We assigned a value of $0 to the warrant, since the value was deemed de minimis and was not an integral part of the investment.
Note 8 – Computation of Earnings per Share
Basic earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding plus additional common shares that would have been outstanding if dilutive potential common shares had been issued. For the purposes of this calculation, stock options are considered common stock equivalents in periods in which they have a dilutive effect. Stock options that are anti-dilutive are excluded from the calculation. Potential common stock equivalents were not included in the per share calculation below for diluted earnings per share, because we had a net loss and the effect of their inclusion would be anti-dilutive.
16
Note 9– Equity and Stock-based compensation
The following table presents stock-based compensation expenses included in our unaudited consolidated statements of operations (in thousands):
|
|
Three Months Ended
June 30, |
|
For the Six Months Ended June 30, |
|
|
|
2022 |
|
|
2021 |
|
2022 |
|
|
2021 |
|
Cost of sales |
|
$ |
7 |
|
|
$ |
6 |
|
$ |
12 |
|
|
$ |
8 |
|
Research and development |
|
|
94 |
|
|
|
66 |
|
|
176 |
|
|
|
97 |
|
Selling and marketing |
|
|
(16 |
) |
|
|
74 |
|
|
79 |
|
|
|
107 |
|
General and administrative |
|
|
294 |
|
|
|
293 |
|
|
541 |
|
|
|
424 |
|
Stock-based compensation expense |
|
$ |
379 |
|
|
$ |
439 |
|
$ |
808 |
|
|
$ |
636 |
|
Stock Options - We did not grant stock options in the three or six months ended June 30, 2022. We granted stock options of 0 and 2,875,000 shares in the three months and six months ended June 30, 2021, respectively.
Unrestricted Stock Grants - We grant unrestricted shares of stock under our 2001 Nonqualified Stock Plan. Stock-based compensation expense for stock grants is determined based on the fair market value of our stock on the date of grant, provided the number of shares in the grant is fixed on the grant date.
In the three and six months ended June 30, 2022 we granted an aggregate of 0 and 107,921 shares of unrestricted stock, respectively. The shares are scheduled to be issued in two installments of 61,460 and 46,461 shortly after June 30, 2022 and December 31, 2022, respectively, provided each grantee is serving as a director, officer or employee on those dates. Total stock-based compensation expense related to these grants is $0.4 million, of which $0.1 million and $0.2 million was charged to expense in the three and six months ended June 30, 2022, respectively. We anticipate the remaining $0.2 million will be charged to expense ratably over the remaining two quarters of 2022.
In the three and six months ended June 30, 2021 we granted an aggregate of 0 and 56,533, respectively, shares of unrestricted stock to directors. The shares were issued in two equal installments shortly after June 30, 2021 and December 31, 2021. Total stock-based compensation expense related to these grants is $0.3 million, of which $0.1 million was charged to expense in the three and six months ended June 30, 2021. The remaining $0.2 million was charged to expense ratably over the remaining two quarters of 2021.
We also granted 120,000 shares in September and October 2019 to be issued in four equal installments shortly after their anniversaries of their grant dates in September and October 2020, 2021, 2022, and 2023, provided the grantee is serving as a director, officer, or employee on those dates. The total stock-based compensation expense related to the 120,000 shares granted is $0.4 million of which $21,000 was charged to expense in each of the three months ended June 30, 2022 and 2021, and $42,000 was charged to expense in each of the six months ended June 30, 2022 and 2021. We anticipate the remaining $0.1 million will be charged to expense ratably through 2023.
Share Purchases - On March 1, 2022, our Board of Directors authorized a new stock repurchase program pursuant to which we may purchase up to $10.0 million of our common stock, of which $3,000 has been utilized as of June 30, 2022. During the three and six months ended June 30, 2022, we purchased 1,154 shares of our common stock. The shares may be purchased from time to time in the open market or through privately negotiated transactions at management’s discretion, depending upon market conditions and other factors. The authorization to repurchase shares of our common stock expires on December 31, 2023. Repurchases will be made under the program using our own cash resources and will be in accordance with Rule 10b-15 under the Securities Exchange Act of 1934, and other applicable laws, rules and regulations, which would permit repurchases to occur during periods when we might otherwise be precluded from making purchases under insider trading laws or company policy. The program does not obligate us to acquire any particular amount of common stock and the program may be modified or suspended at any time at our Board of Director’s discretion.
17
Note 10 – Income Taxes
During the three and six months ended June 30, 2022 and 2021, we recorded no income tax benefits for the net operating losses incurred or for the research and development tax credits generated due to the uncertainty of realizing a benefit from those items.
We have evaluated the positive and negative evidence bearing upon our ability to realize our deferred tax assets, which primarily consist of net operating loss carryforwards and research and development tax credits. We considered the history of cumulative net losses, estimated future taxable income and prudent and feasible tax planning strategies and we have concluded that it is more likely than not that we will not realize the benefits of our deferred tax assets. As a result, as of June 30, 2022 and December 31, 2021, we recorded a full valuation allowance against our net deferred tax assts.
The Coronavirus Aid, Relief and Economic Security Act (CARES Act) was signed into law on March 27, 2020. The CARES Act contained specific relief and stimulus measures including allowing net operating losses originating in 2018 through 2020 to be carried back five years to offset taxable income in the carryback period. Separately, the enactment of the Tax Cut and Jobs Act in 2017 allowed taxpayers to claim a refund for alternative minimum tax credits over a period of years. The CARES Act enacted during the first quarter of 2020 allows for the entire amount of the credit to be refunded. We have reviewed the impact of the CARES Act enactment on the income tax provision and have determined that, as a result of the net operating loss carryback provision, we can obtain a tax benefit if we were to carry back the forecasted 2020 net operating loss to the five year carryback period.
The carryback of the estimated loss would result in a refundable federal tax credit of approximately $1.4 million and an increase in research credit carryforwards previously utilized. The federal tax credit can be refunded in the future, as we decided to carry back the loss reported on the filed 2020 tax return. Upon filing our 2020 tax return, we reclassified the federal tax credit as a current receivable. Due to the recent loss history, continued investments in the Company, and our future projections of income, we will benefit from the 2020 loss to the extent of the available tax refund and will maintain a full valuation allowance on all other deferred tax assets, including any increase in research credit carryforward resulting from a potential carryback.
Note 11 – Lease of Corporate Office
On March 1, 2022 we entered into a Lease Agreement (“Lease”) with 76/80 BURLINGTON GROUP LLC (the “Landlord”). Per the Original Lease, we will lease approximately 20,730 rentable square feet at 76 Blanchard Road in Burlington, Massachusetts (the “Leased Space”) for a term of ten years and six months, which includes a one-time termination right after seven years and six months. We intend to use the Leased Space as our principal executive offices. The term of the Lease commences on the date that the landlord notifies us that the planned construction on the Leased Space is substantially complete. The Lease provides for an aggregate of $8.2 million of rent due over the Lease term and also provides a renewal option for up to two additional terms of five years each.
On March 30, 2022, we entered into a First Amendment of Lease (the “First Amendment”) to our Lease with the Landlord. Pursuant to the First Amendment, we could terminate the Lease by delivering notice to the Landlord at any time prior June 30, 2022. On June 3, 2022, we notified the Landlord that we waived our right to terminate the Lease and the lease will commence once the Landlord completes the buildout which we anticipate will be in September or October of 2022.
Note 12 – Subsequent Event
On April 26, 2021 (the “Contract Date”), we entered into an Agreement of Purchase and Sale (the “Original Agreement”) with FDS Bedford, LLC or its designee (“Purchaser”) relating to the sale by us of the property at 40 Middlesex Turnpike, Bedford, Massachusetts (the “Property”) to the Purchaser for $8.0 million (the “Transaction”)
On November 15, 2021 we entered into an amendment to the Original Agreement where pursuant to which the purchase price for the Property was increased from $8.0 million to $8.9 million.
18
On July 15, 2022 we completed the Transaction and received $8.9 million in funds less a brokerage commission of $0.3 million and deposit already received of $0.3 million. Included in the sale is $2.9 million of net property, equipment and land that we have classified as “Long-Lived Assets held for sale” on the Consolidated Balance Sheet.
19